Related Experiment Video
Updated: Jul 2, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Universal-offer HIV testing amongst patients undergoing blood tests in primary care: results from a multi-centre
Rhys D Wenlock1, Sean Perera1, Jaime H Vera1,2
1The Lawson Unit, University Hospitals Sussex NHS Foundation Trust, Brighton, BN2 5BE, United Kingdom.
Background:
The 2016 NICE guidelines recommend offering HIV testing alongside routine blood tests in areas of high HIV prevalence (>2 per 1000 adults aged 18-59). Despite this, implementation in primary care has been limited.
Method:
A universal-offer HIV testing intervention was implemented across seven general practices in Brighton and Hove. Data were collected on all blood test appointments between June 2022 and February 2024, including demographics, whether an HIV test was offered, patient acceptance, and test results. Mixed-effects logistic regression was used to assess factors associated with test offer and uptake. An electronic survey was disseminated to staff to gather views on feasibility and acceptability.
Results:
Seven sites were recruited, although only four successfully engaged and provided complete data. A total of 6105 HIV tests were conducted, with one new diagnosis identified. HIV testing was offered to 45% of eligible patients, with 74% accepting. Older adults were significantly less likely to be offered a test [aOR 71-80: 0.79 (95% CI: 0.69-0.91); 81+: 0.50 (0.42-0.60)]. Amongst those offered testing, patients aged over 50 were less likely to accept [aOR: 0.72 (0.57-0.91)], with the lowest uptake amongst those aged 81+ [aOR: 0.44 (0.32-0.61)]. Staff reported no barriers to feasibility or patient acceptability.
Conclusion:
Routine HIV testing in primary care is well-accepted and can identify new cases. However, site engagement can be challenging, with closer monitoring, support, and rigorous on-boarding processes required.
Related Concept Videos
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Bioavailability Study Design: Healthy Subjects Versus Patients
Serum Laboratory Studies, Stool Test, Breath Test
